Lakeside Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
8,840
+1
+0% +$132 0.7% 28
2026
Q1
$1.23M Sell
8,839
-261
-3% -$36.5K 0.82% 26
2025
Q4
$1.12M Sell
9,100
-100
-1% -$12.2K 0.71% 27
2025
Q3
$1.02M Sell
9,200
-199
-2% -$22.6K 0.65% 27
2025
Q2
$1.04M Sell
9,399
-799
-8% -$85K 0.67% 29
2025
Q1
$1.14M Sell
10,198
-50
-0.5% -$5.16K 0.76% 27
2024
Q4
$947K Sell
10,248
-599
-6% -$53.9K 0.63% 27
2024
Q3
$909K Sell
10,847
-100
-0.9% -$7.63K 0.57% 29
2024
Q2
$751K Sell
10,947
-400
-4% -$26.7K 0.49% 31
2024
Q1
$831K Sell
11,347
-200
-2% -$15.4K 0.53% 32
2023
Q4
$935K Sell
11,547
-300
-3% -$23.3K 0.65% 29
2023
Q3
$888K Sell
11,847
-850
-7% -$65.4K 0.68% 28
2023
Q2
$979K Sell
12,697
-150
-1% -$12K 0.72% 27
2023
Q1
$1.07M Hold
12,847
0.82% 25
2022
Q4
$1.1M Sell
12,847
-100
-0.8% -$7.92K 0.9% 25
2022
Q3
$799K Hold
12,947
0.72% 28
2022
Q2
$800K Sell
12,947
-150
-1% -$9.29K 0.68% 28
2022
Q1
$779K Buy
13,097
+750
+6% +$47.9K 0.59% 29
2021
Q4
$896K Buy
+12,347
New +$850K 0.66% 27

Other funds holding GILD

Lakeside Advisors's GILD Position: Q2 2026 in Review

Lakeside Advisors increased its Gilead Sciences (GILD) stake by 0.01% in Q2 2026, buying an estimated $132 and bringing the position to 8,840 shares worth $1.12M. The position accounts for 0.7% of the portfolio, ranked #28.

Lakeside Advisors first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.23M in Q1 2026. 1,263 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Lakeside Advisors held 8,840 shares of Gilead Sciences worth $1.12M as of Q2 2026.
  • Lakeside Advisors bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
  • Gilead Sciences made up 0.7% of Lakeside Advisors's portfolio in Q2 2026, its #28 holding.
  • Lakeside Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Lakeside Advisors's Gilead Sciences position peaked at $1.23M in Q1 2026.
  • 1,263 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Lakeside Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.